The tetramerization domain of p53 is required for efficient BAK oligomerization

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• The p53 tumor suppressor protein plays a critical role in preventing cancer through transcriptional regulation and direct mitochondrial apoptosis induction.
• While p53's mitochondrial function is vital for tumor suppression, the mechanisms regulating it remain unclear.
• p53 interacts with BCL2 family members, such as BAK, to mediate apoptosis.

Purpose of the Study:

• To investigate the role of p53 oligomerization in its pro-apoptotic function at the mitochondria.
• To determine how p53 oligomerization influences its interaction with and oligomerization of BAK.
• To elucidate the regulatory mechanisms of p53's mitochondrial activity.

Main Methods:

• Investigated p53 oligomerization domain mutations and deletions.
• Utilized cross-linking studies to assess p53 oligomeric state in mitochondria.
• Compared mitochondrial p53 levels in BAK-null mouse embryo fibroblasts (MEFs) versus wild-type MEFs.

Main Results:

• Deletion or mutation of p53's oligomerization domain significantly impaired its ability to oligomerize BAK.
• Mitochondrial p53 predominantly exists in dimeric or higher-order oligomeric forms.
• BAK-null MEFs exhibited substantially reduced mitochondrial p53 levels compared to wild-type MEFs.

Conclusions:

• p53 oligomerization is crucial for its pro-apoptotic function at the mitochondria, particularly for inducing BAK oligomerization.
• BAK appears to function as a key receptor for p53 on the mitochondria, influencing its localization.
• These findings shed light on the regulation of p53's direct role in apoptosis and tumor suppression.